ClinicalTrials.gov
public full text
Public Domain
Evaluation of Side Effects of Mitotane
Mitotane is standard therapy in the treatment of adrenocortical carcinoma. However, many adverse effects are not well documented. Therefore, we are aiming at collecting data about adverse effects in patients treated with mitotane
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma#878483
- Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists#842712
- Clinical Predictors of Outcome in Advanced Adrenocortical Carcinoma: a multicentre international ENSAT study#218359
- Patient-reported outcome data from a randomized phase II study (STARLIGHT) of fezolinetant in women in Japan with vasomotor symptoms associated with menopause#205368
- Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm#861568
Record · ID 1086182
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive